Skip to main content

“Companies explore the future of the healthcare industry in gut microbiota”

The Basque startup Mikrobiomik, founded in 2018, is competing in the race for the first gut microbiota-based biologic medicine.

Its biologic medicine MBK-01 (full spectrum microbiota capsules) is intended to treat intestinal infection caused by the bacterium ‘Clostridium difficile’.

Read the article (Spanish)

Leave a Reply